Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy
ECHO
A Randomized Controlled Trial of Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy
1 other identifier
interventional
309
1 country
17
Brief Summary
A prospective, multicenter, randomized controlled trial is designed to compare the recurrence rates and clinical outcomes in patients with chronic subdural hematoma using exhaustive drainage or fixed-time drainage after one-burr hole craniostomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2020
CompletedFirst Posted
Study publicly available on registry
October 5, 2020
CompletedStudy Start
First participant enrolled
December 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 9, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedDecember 30, 2024
December 1, 2024
3.5 years
September 26, 2020
December 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of re-operations of chronic subdural hematoma
Rate of re-operations between fixed-time drainage group and exhaustive drainage group
From operation up to 6 months postoperatively
Secondary Outcomes (5)
Change of Modified Rankin Scale (MRS) between groups from baseline to 6 months after operation
At baseline, and at 1, 3, and 6 months after operation
Change of Markwalder Grading Scale (MGS) between groups from baseline to 6 months after operation
At baseline, and at 1, 3, and 6 months after operation
Change of health related quality of life between groups from baseline to 6 months after operation
At baseline, and at 1, 3, and 6 months after operation
Rate of mortality between groups within 6 months
From operation up to 6 months postoperatively
Rate of complications and adverse events between groups within 6 months
From operation up to 6 months postoperatively
Study Arms (2)
Fixed-time drainage
ACTIVE COMPARATORDrainage will be removed after 48 hours.
Exhaustive drainage
EXPERIMENTALDrainage will be removed when postoperative hematoma volume is minimized with repeated urokinase injection into hematoma cavity through catheter.
Interventions
All participants are treated with burr-hole craniotomy and a drainage system as follows. Participants undergo surgical procedure under local anesthesia in the hemisphere with a lateral position, but general anesthesia is performed when participant cannot tolerate the operation. A single 1.5 cm burr hole is drilled over the maximum width of the hematoma cavity. After coagulating with bipolar diathermy, dura mater is opened with a cruciate incision. A soft catheter is placed carefully in all directions of the hematoma cavity for irrigating subdural collections with 1,000 mL warm Ringer's lactate saline until clarification. The drainage catheter is inserted ½ length of the maximum diameter of the hematoma cavity toward the frontal region. After the skin is closed, the catheter was connected to a soft collection bag that is placed under the head for passive drainage. During the drainage period, participants stay in bed until the drain is removed.
All participants will be treated with a one-burr-hole craniotomy with irrigation and a closed drainage system. The drainage will be removed after 48 hours.
All participants will be treated with a one-burr-hole craniotomy with irrigation and a closed drainage system. If the computed tomography (CT) scan on the first day after surgery indicates that the affected brain region shows sufficient re-expansion, the drainage catheter will be removed when drainage ceases. If subdural collections remain in the hematoma cavity, the participant will be treated with 30,000 U urokinase injection into the hematoma cavity through the catheter. The catheter will be closed and reopened in 1.5-2 hours, and a CT scan will be performed when drainage ceases. If the CT scan shows sufficient re-expansion of the brain, the catheter will be removed. However, if the brain does not show good re-expansion and there is still a residual subdural collection, the above steps will be repeated. If the participant is subjected to urokinase injection for 3 times, the catheter will be removed when drainage ceases.
All participants undergo a CT scan before the drain is removed, and the last CT scan will be performed before the patient is discharged from the hospital.
Eligibility Criteria
You may qualify if:
- Patient (18 years to 90 years) presenting with clinical symptoms and neurological deficits of chronic subdural hematoma
- Chronic subdural hematoma verified on cranial computed tomography or magnetic resonance imaging
- Written informed consent from patients or their next of kin according to the patient's cognitive status
You may not qualify if:
- No clinical symptoms correlating with chronic subdural hematoma
- Lack of mass effect, less than 0.5 cm of midline structure shift, and no need surgery judged clinically by neurosurgeons
- Previous surgery for chronic subdural hematoma during the past 6 months
- Previous intracranial surgery for any neurological disorders but chronic subdural hematoma before
- Existing poor medication condition or severe comorbidity so that surgery cannot be tolerated or follow-up cannot be completed
- Severe coagulopathy or high risk of life-threatening bleeding
- Postoperative cooperation is suspected to be insufficient for follow-up for 6 months
- Reproductive-age women without verified negative pregnancy testing
- Participating in other research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
Beijing Ditan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100015, China
Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, 100020, China
Beijing Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, 100053, China
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100730, China
Beijing Luhe Hospital, Capital Medical University
Beijing, Beijing Municipality, 101100, China
Wangjing Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
Puning People's Hospital
Puning, Guangdong, 515300, China
Wei County Hospital of Traditional Chinese Medicine
Handan, Hebei, 056800, China
Hengshui People's Hospital
Hengshui, Hebei, 053000, China
First Hospital of Qinhuangdao
Qinhuangdao, Hebei, 066000, China
North China University of Science and Technology Affiliated Hospital
Tangshan, Hebei, 063000, China
Xiahuayuan District Hospital
Zhangjiakou, Hebei, 075000, China
First People's Hospital of Lianyungang
Lianyungang, Jiangsu, 222061, China
Yancheng Third People's Hospital
Yancheng, Jiangsu, 224001, China
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, Ningxia, 750002, China
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, 300350, China
Related Publications (7)
Ou Y, Yu X, Liu X, Jing Q, Liu B, Liu W. A Comparative Study of Chronic Subdural Hematoma in Patients With and Without Head Trauma: A Retrospective Cross Sectional Study. Front Neurol. 2020 Nov 27;11:588242. doi: 10.3389/fneur.2020.588242. eCollection 2020.
PMID: 33329333BACKGROUNDOu Y, Dong J, Wu L, Xu L, Wang L, Liu B, Li J, Liu W. An Exhaustive Drainage Strategy in Burr-hole Craniostomy for Chronic Subdural Hematoma. World Neurosurg. 2019 Jun;126:e1412-e1420. doi: 10.1016/j.wneu.2019.03.111. Epub 2019 Mar 19.
PMID: 30902781BACKGROUNDOu Y, Dong J, Wu L, Xu L, Wang L, Liu B, Li J, Liu W. The Clinical Characteristics, Treatment, and Outcomes of Chronic Subdural Hematoma in Young Patients. World Neurosurg. 2019 May;125:e1241-e1246. doi: 10.1016/j.wneu.2019.02.017. Epub 2019 Feb 22.
PMID: 30797913BACKGROUNDOu Y, Dong J, Wu L, Xu L, Wang L, Liu B, Li J, Liu W. A comparative study of chronic subdural hematoma in three age ranges: Below 40 years, 41-79 years, and 80 years and older. Clin Neurol Neurosurg. 2019 Mar;178:63-69. doi: 10.1016/j.clineuro.2019.01.018. Epub 2019 Jan 29.
PMID: 30716602BACKGROUNDLiu W, Bakker NA, Groen RJ. Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg. 2014 Sep;121(3):665-73. doi: 10.3171/2014.5.JNS132715. Epub 2014 Jul 4.
PMID: 24995782BACKGROUNDWu L, Ou Y, Liu W. Letter to the Editor. Benefit of postoperative computed tomography in chronic subdural hematoma. J Neurosurg. 2019 Sep 13;131(6):1992-1993. doi: 10.3171/2019.5.JNS191212. Print 2019 Dec 1. No abstract available.
PMID: 31518980BACKGROUNDWu L, Ou Y, Zhu B, Guo X, Yu X, Xu L, Li J, Feng E, Li H, Wang X, Chen H, Sun Z, Liu Z, Yang D, Zhang H, Liu Z, Tang J, Zhao S, Zhang G, Yao J, Ma D, Sun Z, Zhou H, Liu B, Liu W; ECHO Trial Collaborators. Exhaustive drainage versus fixed-time drainage for chronic subdural hematoma after one-burr hole craniostomy (ECHO): study protocol for a multicenter randomized controlled trial. Trials. 2023 Mar 20;24(1):207. doi: 10.1186/s13063-023-07250-y.
PMID: 36941714DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Weiming Liu, MD
Beijing Tiantan Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The design is open labeled with only the investigators for postoperative follow-up evaluation, the outcome assessors, and data analysts being blinded in all 19 centers. Before outcome assessment begins at every follow-up evaluation, the patients will be reminded not to reveal any information about their group allocation. If details of group allocation can be detected by the investigator during follow-ups, another blinded researcher will replace to evaluate outcome.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 26, 2020
First Posted
October 5, 2020
Study Start
December 29, 2020
Primary Completion
July 9, 2024
Study Completion
December 15, 2024
Last Updated
December 30, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share